Terms: = Ependymoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
21 results:
1. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
Rana R; Sharma S; Ganguly NK
Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
[TBL] [Abstract] [Full Text] [Related]
2. A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
Gilbert MR; Yuan Y; Wu J; Mendoza T; Vera E; Omuro A; Lieberman F; Robins HI; Gerstner ER; Wu J; Wen PY; Mikkelsen T; Aldape K; Armstrong TS
Neuro Oncol; 2021 Mar; 23(3):468-477. PubMed ID: 33085768
[TBL] [Abstract] [Full Text] [Related]
3. Glioma Subclassifications and Their Clinical Significance.
Chen R; Smith-Cohn M; Cohen AL; Colman H
Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
[TBL] [Abstract] [Full Text] [Related]
4. The genetic basis of intradural spinal tumors and its impact on clinical treatment.
Karsy M; Guan J; Sivakumar W; Neil JA; Schmidt MH; Mahan MA
Neurosurg Focus; 2015 Aug; 39(2):E3. PubMed ID: 26235020
[TBL] [Abstract] [Full Text] [Related]
5. Intramedullary spinal cord tumors: a review of current and future treatment strategies.
Tobin MK; Geraghty JR; Engelhard HH; Linninger AA; Mehta AI
Neurosurg Focus; 2015 Aug; 39(2):E14. PubMed ID: 26235012
[TBL] [Abstract] [Full Text] [Related]
6. Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
Sie M; den Dunnen WF; Lourens HJ; Meeuwsen-de Boer TG; Scherpen FJ; Zomerman WW; Kampen KR; Hoving EW; de Bont ES
PLoS One; 2015; 10(3):e0122555. PubMed ID: 25799134
[TBL] [Abstract] [Full Text] [Related]
7. Prolonged use of nimotuzumab in children with central nervous system tumors: safety and feasibility.
Cabanas R; Saurez G; Alert J; Reyes A; Valdes J; Gonzalez MC; Pedrayes JL; Valle L; Infante M; Avila M; Herrera R; Hechavarria E; Rios M; Fernández A; Lorenzo Luaces P; Crombet Ramos T
Cancer Biother Radiopharm; 2014 May; 29(4):173-8. PubMed ID: 24784755
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features of myxopapillary ependymoma.
Wang H; Zhang S; Rehman SK; Zhang Z; Li W; Makki MS; Zhou X
J Clin Neurosci; 2014 Apr; 21(4):569-73. PubMed ID: 24332590
[TBL] [Abstract] [Full Text] [Related]
9. A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
Fouladi M; Stewart CF; Blaney SM; Onar-Thomas A; Schaiquevich P; Packer RJ; Goldman S; Geyer JR; Gajjar A; Kun LE; Boyett JM; Gilbertson RJ
J Neurooncol; 2013 Sep; 114(2):173-9. PubMed ID: 23836190
[TBL] [Abstract] [Full Text] [Related]
10. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract] [Full Text] [Related]
11. Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models.
Servidei T; Meco D; Trivieri N; Patriarca V; Vellone VG; Zannoni GF; Lamorte G; Pallini R; Riccardi R
Int J Cancer; 2012 Sep; 131(5):E791-803. PubMed ID: 22120695
[TBL] [Abstract] [Full Text] [Related]
12. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.
Ammoun S; Hanemann CO
Nat Rev Neurol; 2011 Jun; 7(7):392-9. PubMed ID: 21647202
[TBL] [Abstract] [Full Text] [Related]
13. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract] [Full Text] [Related]
14. Intracranial ependymoma: factors affecting outcome.
Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
[TBL] [Abstract] [Full Text] [Related]
15. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract] [Full Text] [Related]
16. egfr tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
Geoerger B; Gaspar N; Opolon P; Morizet J; Devanz P; Lecluse Y; Valent A; Lacroix L; Grill J; Vassal G
Int J Cancer; 2008 Jul; 123(1):209-16. PubMed ID: 18386816
[TBL] [Abstract] [Full Text] [Related]
17. ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.
Rich JN; Sathornsumetee S; Keir ST; Kieran MW; Laforme A; Kaipainen A; McLendon RE; Graner MW; Rasheed BK; Wang L; Reardon DA; Ryan AJ; Wheeler C; Dimery I; Bigner DD; Friedman HS
Clin Cancer Res; 2005 Nov; 11(22):8145-57. PubMed ID: 16299247
[TBL] [Abstract] [Full Text] [Related]
18. Prognosis-related molecular markers in pediatric central nervous system tumors.
Rickert CH
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1211-24. PubMed ID: 15624758
[TBL] [Abstract] [Full Text] [Related]
19. Establishment of human tumoral ependymal cell lines and coculture with tubular-like human endothelial cells.
Brisson C; Lelong-Rebel I; Mottolèse C; Jouvet A; Fèvre-Montange M; Saint Pierre G; Rebel G; Belin MF
Int J Oncol; 2002 Oct; 21(4):775-85. PubMed ID: 12239616
[TBL] [Abstract] [Full Text] [Related]
20. Spinal ependymomas--the value of postoperative radiotherapy for residual disease control.
Sgouros S; Malluci CL; Jackowski A
Br J Neurosurg; 1996 Dec; 10(6):559-66. PubMed ID: 9115651
[TBL] [Abstract] [Full Text] [Related]
[Next]
